Role of Bile Acid Sequestrants in the Treatment of Type 2 Diabetes

May 2011
Diabetes Care;May2011 Supplement 2, Vol. 34, pS244
Academic Journal
The article discusses the rationale for the use of a bile acid sequestrant (BAS) to treat type 2 diabetes. It describes the clinical effects of the BAS, known as colesevelam hydrochloride, that has been approved for both glycemic and lipid control in the U.S. As new agents are approved in the market, the treatment strategies for type 2 diabetes also changed. Example of oral anti-diabetes agents include biguanides, BAS, and dipeptidyl peptidase-4 inhibitors. Aside from BAS, other lipid-lowering agents used to treat hypercholesterolemia are listed.


Related Articles

  • STEROID AND BILE ACIDS AMIDE CONJUGATES WITH D-GLUCOSAMINE. NovákovÎ, Zdena; Tomanová, Jana; Štěrbová, Lucie; Drašar, Pavel // Collection of Czechoslovak Chemical Communications;2011, Vol. 76 Issue 1, p65 

    New type of amide conjugates of steroid and bile acids with D-glucosamine 1 and 2 were prepared. Title compounds are prepared via acid chloride or using N-[(([(1E)-1-cyano-2-ethoxy-2-oxoethylidene]amino)oxy)(dimethylamino)methylidene]-N-methylmethanaminium tetrafluoroborate as condensation...

  • Dysbiosis modulates capacity for bile acid modification in the gut microbiomes of patients with inflammatory bowel disease: a mechanism and marker of disease? Ogilvie, Lesley A.; Jones, Brian V. // Gut;Nov2012, Vol. 61 Issue 11, p1642 

    A letter to the editor is presented in the response of a research paper published in the previous issue of the periodical on the topic modulation of bile acid modification by dysbiosis.

  • Does loss of bile acid homeostasis make mice melancholy? Moore, David D. // Journal of Clinical Investigation;10/15/2002, Vol. 110 Issue 8, p1067 

    Presents information on bile acids that function as hormones and are received by farsenoid X receptor, a member of the nuclear receptor family. Negative feedback regulation of bile acid synthesis; Various regulatory effects of bile acids; Results of a study which provided evidence of the...

  • Gall bladder function after endoscopic sphincterotomy. Desa, L.A.; Grace, P.A.; Vipond, M.N.; Henderson, B.; Thompson, J.N. // BMJ: British Medical Journal (International Edition);4/28/90, Vol. 300 Issue 6732, p1111 

    Describes the function of the gall bladder after endoscopic sphincterotomy. Effects of sphincterotomy on the bile duct; Implications of the findings; Obstruction of the cystic duct.

  • Corrigendum: A Randomized Placebo-Controlled Phase IIb Trial of A3309, A Bile Acid Transporter Inhibitor, for Chronic Idiopathic Constipation. Chey, William D; Camilleri, Michael; Chang, Lin; Rikner, Leif; Graffner, Hans // American Journal of Gastroenterology;May2014, Vol. 109 Issue 5, p782 

    A correction to the article "A Randomized Placebo-Controlled Phase IIb Trial of A3309, A Bile Acid Transporter Inhibitor, for Chronic Idiopathic Constipation" that was published in the previous issue is presented.

  • Reversal of clofibrate-induced cholesterol oversaturation of bile with chenodeoxycholic acid. Bateson, M.C.; Ross, P.E.; Murison, J.; Bouchier, Ian A.D. // British Medical Journal;5/6/1978, Vol. 1 Issue 6121, p1171 

    Giving clofibrate 2 g daily to seven patients significantly increased the biliary cholesterol concentration while the proportion of bile acids fell. Five patients on established clofibrate treatment were given 750 mg of chenodeoxycholic acid (CDCA) daily for one month. Biliary lipid analysis...

  • Treatment with bile acids.  // British Medical Journal;7/29/1978, Vol. 2 Issue 6133, p309 

    Analyzes the effective treatment for gallstone with bile acids in Great Britain. Reduction of weight for the obese patients; Process for the dissolution of gallstones; Significance on the discovery of chenodeoxycholic acid.

  • Letter to the editors. Peters, Jeffrey H. // Journal of Gastrointestinal Surgery;Feb2008, Vol. 12 Issue 2, p400 

    A letter to the editor is presented in response to the article "The Pathogenesis of Barrett's Esophagus: Secondary Bile Acids Upregulate Intestinal Differentiation Factor CDX2 Expression in Esophageal Cells," in the July 2007 issue.

  • Postcholecystectomy Microscopic Colitis: Is Bile Acid Malabsorption a Triggering Factor? Gurbuz, Yesim; Senturk, Otner; Muezzinoğlu, Bahar // American Journal of Gastroenterology;May2001, Vol. 96 Issue 5, p1655 

    Presents a letter to the editor about the involvement of bile acid malabsorption in postcholecystectomy diarrhea.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics